Relation of serum reverse T3 to amiodarone antiarrhythmic efficacy and toxicity

This publication has 16 references indexed in Scilit:

• Intravenous and oral loading versus oral loading alone with amiodarone for chronic refractory ventricular arrhythmias
  The American Journal of Cardiology, 1985
• Amiodarone: Correlation of serum concentration with suppression of complex ventricular ectopic activity
  The American Journal of Cardiology, 1984
• Multicenter controlled observation of a low-dose regimen of amiodarone for treatment of severe ventricular arrhythmias
  The American Journal of Cardiology, 1984
• Clinical pharmacokinetics and efficacy of amiodarone for refractory tachyarrhythmias.
  Circulation, 1983
• Serum concentrations of amiodarone during long term therapy. Relation to dose, efficacy and toxicity
  European Journal of Clinical Pharmacology, 1983
• Pharmacokinetic significance of serum reverse T3 levels during amiodarone treatment: a potential method for monitoring chronic drug therapy.
  Circulation, 1982
• Effect of amiodarone on serum triiodothyronine, reverse triiodothyronine, thyroxin, and thyrotropin. A drug influencing peripheral metabolism of thyroid hormones.
  Journal of Clinical Investigation, 1976
• An assessment of daily production and significance of thyroidal secretion of 3, 3', 5'-triiodothyronine (reverse T3) in man.
  Journal of Clinical Investigation, 1976
• Effects of amiodarone on thyroid function in patients with ischaemic heart disease.
  Heart, 1975
• A Radioimmunoassay for Measurement of 3,3′, 5′-Triiodothyronine (Reverse T3)
  Journal of Clinical Investigation, 1974